Borrower record · Q2 2026
enGene Therapeutics
As filed by Hercules Capital, Inc. · period end 30 June 2026No sector — one filer, nothing to corroborate
Hercules Capital, Inc. is the only BDC lending to enGene Therapeutics: $18.0m across two positions at Q2 2026, marked at 99.1 cents.
- Filed fair value
- $18.0m
- 2 funded positions
- Aggregate mark
- 99.1c
- cost filed on all 2 positions
- Filed spread
- 225bp
- over Prime, one floating tranche
- Maturities to
- 2030
- one date, 1 January 2030
- Periods on record
- 1
- first seen Q2 2026
How this total is counted
- Every figure above is the sum of 2 funded positions filed by Hercules Capital, Inc., each one cited below.
- Counted from the Q2 2026 filings imported for this build, the latest of them filed 20 August 2026. A schedule filed after that date is not in these figures and will appear when the property is rebuilt.
Capital structure
All 2 funded positions carry a filed seniority.
Rate structure
Floating, on the one position whose interest type a filer disclosed.
1 of 2 funded positions carries no filed interest type.
Maturity profile
1 of 2 funded positions dated3.5 years to maturity, weighted by fair value across the 1 dated position.
Credit flags
The filer reports no position on non-accrual, and no filed tranche pays in kind.
Not in the filings
- No sector, and there cannot be one: the test needs two filers to agree and only one filed a label.
- No maturity on 1 of 2 funded positions. Undated is left undated, not assumed.
- One floating tranche, so there is no spread range to publish — the single filed spread is above.
- No index floor filed on any tranche.
Sign up for free
Tell me when this changes.
One lender reports enGene Therapeutics today. We will email you when a second one does, when Hercules Capital, Inc.'s mark moves, or when the position leaves the schedule.
- A second BDC reports this borrower
- The filed mark moves by more than two cents
- A position goes on non-accrual or starts paying in kind
- The borrower drops out of the schedule entirely
Every filing behind this page
1 filer · Q2 2026| Filer | CIK | Form | Period | Filed | Accession |
|---|---|---|---|---|---|
| Hercules Capital, Inc. (HTGC) | 0001280784 | 10-Q | 2026-06-30 | 2026-07-30 | 0001280784-26-000042 |
Related borrowers
Same lender